PGR and breast carcinoma: Invasive breast cancers that are positive for the estrogen receptor and/or the progesterone receptor can be managed systemically with a variety of endocrine agents, such as tamoxifen for premenopausal patients and tamoxifen or one of the aromatase inhibitors for postmenopausal patients.